產(chǎn)品編號(hào) | bs-47026P |
英文名稱 | Recombinant human CD86 / B7-2 protein, C-His-Avi (HEK293) |
中文名稱 | 重組人CD86/B7-2蛋白 |
別 名 | CD28LG2; FUN1; LAB72; Activation B7 2 antigen; Activation B7-2 antigen 3; CD86_HUMAN; Activation B7-2 antigen; Activation B72 antigen; B lymphocyte activation antigen B7 2; B lymphocyte activation antigen B72; B-lymphocyte activation antigen B7-2 2; B-lymphocyte activation antigen B7-2; B7 2; B7 2 antigen; B7; B7-2; B7.2; B70; B72 antigen; BU63; CD 86; CD28 antigen ligand 2 2; CD28 antigen ligand 2; Cd28l2; CD28LG2; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) 1, 2; CD86 antigen; CD86 molecule; CLS1; CTLA 4 counter receptor B7 2; CTLA 4 counter receptor B7.2; CTLA-4 counter-receptor B7.2 2, 3; CTLA4 counter receptor B72; Early T-cell costimulatory molecule 1; ETC-1; FUN 1; LAB72; Ly-58; Ly58; MB7; MB7-2; Membrane glycoprotein; MGC34413; T lymphocyte activation antigen CD86; T-lymphocyte activation antigen CD86; TS/A-2; Recombinant human CD86 / B7-2 protein, C-His-Avi (HEK293) |
理論分子量 | 28.2kDa |
檢測(cè)分子量 | Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result. |
性 狀 | Lyophilized powder |
濃 度 | >0.5 mg/ml |
物 種 | Human |
序 列 | 26-247/329 |
純 度 | >95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC |
純化方法 | AC |
內(nèi)毒素 | <1.0 EU/μg as determined by LAL |
表達(dá)系統(tǒng) | HEK293 cell |
活性 | Not tested |
標(biāo)簽 | C-His-Avi |
緩 沖 液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4) with 5 mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產(chǎn)品介紹 | |
產(chǎn)品圖片 | |
我要詢價(jià)
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會(huì)被公開(kāi))
*內(nèi)容: